FDA approves Ionis’ TRYNGOLZA for FCS treatment
The US Food and Drug Administration (FDA) has approved Ionis Pharmaceuticals' TRYNGOLZA (olezarsen), designed as an adjunct to diet for…
News
Novo Nordisk takes a hit as CagriSema underperforms in weight loss
FDA confirms end of Eli Lilly’s tirzepatide shortage after re-evaluation
Palleon and Shanghai Henlius Biotech link on autoimmune therapy
Astellas and Sangamo sign capsid deal for neurological diseases
Vertex’s stock hurt after non-opioid pain drug shows benefit similar to placebo
FDA approves Mesoblast’s Ryoncil for SR-aGvHD treatment
MSD makes obesity play in up to $2bn deal for Hansoh’s GLP-1RA asset
